Common genetic variants in metabolism and detoxification pathways and the risk of papillary thyroid cancer

Endocrine-Related Cancer

Volumn 19, Issue 3, 2012, Pages 333-344

  Aschebrook Kilfoy, Briseis ^a,b   Neta, Gila ^a   Brenner, Alina V ^a   Hutchinson, Amy ^a   Pfeiffer, Ruth M ^a   Sturgis, Erich M ^c   Xu, Li ^c   Wheeler, William ^d   Doody, Michele M ^a   Chanock, Stephen J ^a   Sigurdson, Alice J ^a  

^a NATIONAL INSTITUTES OF HEALTH   (United States)

^b UNIVERSITY OF CHICAGO   (United States)

^c UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^d INFORMATION MANAGEMENT SERVICES INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACYLTRANSFERASE; ALCOHOL; CYTOCHROME P450; CYTOCHROME P450 26B1; GLUCURONOSYLTRANSFERASE 2B7; N ACETYLTRANSFERASE 1; UNCLASSIFIED DRUG;

ADULT; AGED; ALCOHOL CONSUMPTION; ALCOHOL METABOLISM; ARTICLE; CANCER RISK; CONTROLLED STUDY; DETOXIFICATION; ENVIRONMENTAL EXPOSURE; ENVIRONMENTAL FACTOR; FEMALE; GENE INTERACTION; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENETIC VARIABILITY; HUMAN; HUMAN TISSUE; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; METABOLISM; METAL BINDING; OXIDATIVE STRESS; PROTEIN INTERACTION; RISK ASSESSMENT; RISK FACTOR; SINGLE NUCLEOTIDE POLYMORPHISM; THYROID PAPILLARY CARCINOMA; TOBACCO;

ADULT; AGED; ALCOHOL DRINKING; COHORT STUDIES; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; MALE; MIDDLE AGED; ODDS RATIO; POLYMORPHISM, SINGLE NUCLEOTIDE; SMOKING; THYROID NEOPLASMS;

EID: 84862687849     PISSN: 13510088     EISSN: 14796821     Source Type: Journal    
DOI: 10.1530/ERC-11-0372     Document Type: Article

References (30)

1. Barter RA & Klaassen CD 1994 Reduction of TH levels and alteration of thyroid function by four representative UDP-glucuronosyltransferase inducers in rats. Toxicology and Applied Pharmacology 128 9-17. (doi:10.1006/taap.1994. 1174)
2. Benjamini Y & Hochberg Y 1995 Controlling the false discovery rate: a practical and powerful approach to multiple testing. Journal of the Royal Statistical Society 57 289-300.
3. Carlson CS, Eberle MA, Rieder MJ & Yi Q 2004 Selecting a maximally informative set of single-nucleotide polymorphisms for association analyses using linkage disequilibrium. American Journal of Human Genetics 74 106-120. (doi:10.1086/381000)
4. De Felice M & Di Lauro R 2004 Thyroid development and its disorders: genetics and molecular mechanisms. Endocrine Reviews 25 722-746. (doi:10.1210/er.2003-0028)
5. Gudmundsson J, Sulem P, Gudbjartsson DF, Jonasson JG, Sigurdsson A, Bergthorsson JT, He H, Blondal T, Geller F, Jakobsdottir M et al. 2009 Common variants on 9q22.33 and 14q13.3 predispose to thyroid cancer in European populations. Nature Genetics 41 460-464. (doi:10.1038/ng.339)
6. Gudmundsson J, Sulem P, Gudbjartsson DF, Jonasson JG, Masson G, He H, Jonasdottir A, Sigurdsson A, Stacey SN, Johannsdottir H et al. 2012 Discovery of common variants associated with low TSH levels and thyroid cancer risk. Nature Genetics 44 319-322. (doi: 10.1038/ng.1046)
7. Guignard R, Truong T, Rougier Y, Baron-Dubourdieu D &Guénel P 2007 Alcohol drinking, tobacco smoking, and anthropometric characteristics as risk factors for thyroid cancer: a countrywide case-control study in New Caledonia. American Journal of Epidemiology 166 1140-1149. (doi:10.1093/aje/ kwm204)
8. Guilhen AC, Bufalo NE, Morari EC, Leite JL, Assumpcao LV, Tincani AJ & Ward LS 2009 Role of the N-acetyltransferase 2 detoxification system in thyroid cancer susceptibility. Clinical Cancer Research 15 406-412. (doi:10.1158/1078-0432.CCR-08-1835)
9. Hein DW, Doll MA, Fretland AJ, Leff MA, Webb SJ, Xiao GH, Devanaboyina US, Nangju NA & Feng Y 2009 Molecular genetics and epidemiology of the NAT1 and NAT2 acetylation polymorphisms. Cancer Epidemiology, Biomarkers & Prevention 9 29-42.
10. Hernández A, Xamena N, Surrallés J, Galofré P, Velázquez A, Creus A & Marcos R 2008 Role of GST and NAT2 polymorphisms in thyroid cancer. Journal of Endocrinological Investigation 31 1025-1031.
11. Ho T, Li G, Lu J, Zhao C, Wei Q & Sturgis EM 2009 Association of XRCC1 polymorphisms and risk of differentiated thyroid carcinoma: a case-control analysis. Thyroid 19 129-135. (doi:10.1089/thy.2008.0153)
12. Hood A, Hashmi R & Klaassen CD 1999 Effects of microsomal enzyme inducers on thyroid-follicular cell proliferation, hyperplasia, and hypertrophy. Toxicology and Applied Pharmacology 160 163-170. (doi:10.1006/taap.1999.8752)
13. Howlader N, Noone AM, Krapcho M, Neyman N, Aminou R, Waldron W, Altekruse SF, Kosary CL, Ruhl J, Tatalovich Z et al. 2011 SEER Cancer Statistics Review, 1975-2008, National Cancer Institute. Bethesda, MD, http://seer.cancer.gov/csr/ 1975-2008/, based on November 2010 SEER data submission, posted to the SEER web site, 2011.
14. Klaassen CD & Hood AM 2001 Effects of microsomal enzyme inducers on thyroid follicular cell proliferation and TH metabolism. Toxicologic Pathology 29 34-40. (doi:10.1080/019262301301418838)
15. Landa I & Robledo M 2011 Association studies in thyroid cancer susceptibility: are we on the right track? Journal of Molecular Endocrinology 47 R43-R58. (doi:10.1530/JME-11-0005)
16. Lemos MC, Carrilho F, Rodrigues F, Coutinho E, Gomes L, Carvalheiro M & Regateiro FJ 2007 Genetic polymorphism of CYP2D6 influences susceptibility to papillary thyroid cancer. Clinical Endocrinology 67 180-183. (doi:10.1111/j.1365-2265.2007.02858.x)
17. Lemos MC, Coutinho E, Gomes L, Carrilho F, Rodrigues F, Regateiro FJ & Carvalheiro M 2008 Combined GSTM1 and GSTT1 null genotypes are associated with a lower risk of papillary thyroid cancer. Journal of Endocrinological Investigation 31 542-545.
18. Liu J, Liu Y, Barter RA & Klaassen CD 1995 Alteration of thyroid homeostasis by UDP-glucuronosyltransferase inducers in rats: a dose-response study. Journal of Pharmacological and Experimental Therapeutics 273 977-985.
19. Lönn S, Bhatti P, Alexander BH, Pineada MA, Doody MM, Struewing JP & Sigurdson A 2007 Papillary thyroid cancer and polymorphic variants in TSHR- and RET-related genes: a nested case-control study within a cohort of US radiologic technologists. Cancer Epidemiology, Biomarkers & Prevention 16 174-177. (doi:10.1158/1055-9965.EPI-06-0665)
20. Mack WJ, Preston-Martin S, Dal Maso L, Galanti R, Xiang M, Franceschi S, Hallquist A, Jin F, Kolonel L, La Vecchia C et al. 2003 A pooled analysis of case-control studies of thyroid cancer: cigarette smoking and consumption of alcohol, coffee, and tea. Cancer Causes and Control 14 773-785. (doi:10.1023/A:1026349702909)
21. Meinhold CL, Park Y, Stolzenberg-Solomon RZ, Hollenbeck AR, Schatzkin A & Berrington de Gonzalez A 2009 Alcohol intake and risk of thyroid cancer in the NIH-AARP Diet and Health Study. British Journal of Cancer 101 1630-1634. (doi:10.1038/sj.bjc.6605337)
22. Meinhold CL, Ron E, Schonfeld SJ, Alexander BH, Freedman DM, Linet MS & Berrington de González A 2010 Nonradiation risk factors for thyroid cancer in the US Radiologic Technologists Study. American Journal of Epidemiology 171 242-252. (doi:10.1093/aje/kwp354)
23. Panicker V, Cluett C, Shields B, Murray A, Parnell KS, Perry JR, Weedon MN, Singleton A, Hernandez D, Evans J et al. 2008 A common variation in deiodinase 1 gene DIO1 is associated with the relative levels of free thyroxine and triiodothyronine. Journal of Clinical Endocrinology and Metabolism 93 3075-3081. (doi:10.1210/jc.2008-0397)
24. Rossing MA, Cushing KL & Voigt LF 2000 Risk of papillary thyroid cancer in women in relation to smoking and alcohol consumption. Epidemiology 11 49-54. (doi:10. 1097/00001648-200001000-00011)
25. Sanderson S, Salanti G & Higgins J 2007 Joint effects of the N-acetyltransferase 1 and 2 (NAT1 and NAT2) genes and smoking on bladder carcinogenesis: a literature-based systematic HuGE review and evidence synthesis. American Journal of Epidemiology 166 741-751. (doi:10.1093/aje/ kwm167)
26. Sigurdson AJ, Doody MM, Rao RS, Freedman DM, Alexander BH, Hauptmann M, Mohan AK, Yoshinaga S, Hill DA & Tarone R 2003 Cancer incidence in the US radiologic technologists health study, 1983-1998. Cancer 97 3080-3089. (doi:10.1002/cncr.11444)
27. Siraj AK, Ibrahim M, Al-Rasheed M, Abubaker J, Bu R, Siddiqui SU, Al-Dayel F, Al-Sanea O, Al-Nuaim A, Uddin S et al. 2008 Polymorphisms of selected xenobiotic genes contribute to the development of papillary thyroid cancer susceptibility in Middle Eastern population. BMC Medical Genetics 9 61. (doi:10.1186/1471-2350-9-61)
28. Takahashi M, Saenko VA, Rogounovitch TI, Kawaguchi T, Drozd VM, Takigawa-Imamura H, Akulevich NM, Ratanajaraya C, Mitsutake N, Takamura N et al. 2010 The FOXE1 locus is a major genetic determinant for radiation-related thyroid carcinoma in Chernobyl. Human Molecular Genetics 19 2516-2523. (doi:10.1093/hmg/ddq123)
29. Tarone RE 1990 A modified Bonferroni method for discrete data. Biometrics 46 515-522. (doi:10.2307/2531456)
30. Yu K, Li Q, Bergen AW, Pfeiffer RM, Rosenberg PS, Caporaso N, Kraft P & Chatterjee N 2009 Pathway analysis by adaptive combination of P-values. Genetic Epidemiology 33 700-709. (doi:10.1002/gepi.20422)